Combined expression of MKI67, FOXC1 and PDL1 is a pantumor tissue-agnostic predictor of PD1/PDL1 inhibitor efficacy in metastatic renal cell cancer: Validation in checkmate 009, 010 and 025 clinical trial cohorts-MedSci.cn

Combined expression of MKI67, FOXC1 and PDL1 is a pantumor tissue-agnostic predictor of PD1/PDL1 inhibitor efficacy in metastatic renal cell cancer: Validation in checkmate 009, 010 and 025 clinical trial cohorts

Ray, PS; Ray, T; Taylor, C; Hussa, R

ANNALS OF ONCOLOGY, 2023; 34 (): S249

科室
- - 订阅+
  - 更多科室
工具
服务